Page 12 - Pharmaceutical

Sun Pharma receives US FDA nod for diabetes drug metformin ER tablets

These tablets, which are generic versions of Glumetza, have annual sales of approximately $ 1.2 billion in the US, according to IMS Health

Lupin acquires 21 branded products from Japan's Shionogi for $ 150 mn

These 21 products, covering therapy areas such as central nervous system (CNS), oncology, cardiovascular and anti-infectives, had sales of Yen 9.4 bn ($ 90 million) collectively

Suven receives patents for CNS drug in Macau and New Zealand

These patents are valid through 2032

Borosil Glass buys 60% stake in glass packaging company Klasspack

With this, Borosil has entered into primary pharma glass packaging business

China's Fosun Pharma acquires 86% stake in Gland Pharma for $ 1.26 bn

Acquisition will help Fosun Pharma to strengthen its presence in the global injectables market - one of the fastest growing segment within pharma industry

Amend Drugs and Cosmetics Act to promote e-pharmacy in India

While e-pharmacy offers convenience to people, there are concerns with respect to legitimacy of e-pharmacies, patients' safety and privacy, adverse effect on retailers business, etc

Sun Pharma signs licensing pact with Spain's Almirall for tildrakizumab in Europe

As per the agreement, which will fetch Sun Pharma $ 50 mn as an initial upfront payment, Almirall will lead the marketing effort of tildrakizumab for treatment of psoriasis in Europe

RPG Life Sciences buys Sun Pharma's 7 brands for Rs 41 crore

Divested products include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases, etc

Vivimed arm Klar Sehen divests certain products to Ordain Healthcare for Rs 73 cr

The move is part of Vivimed's strategy to exit from the branded formulations in ophthalmology and to focus on CMO and US generic business

European drug regulator suspends medicines tested at Semler Research

European Medicines Agency has cited flaws in bioequivalence studies, which are required for the approval of generics, conducted at the Bangalore-based CRO as the reasons for suspension

US FDA grants approval for Glenmark's skin ointment

The approved product, triamcinolone acetonide ointment (0.5 percent), achieved annual sales of about $ 4.4 million in the US, according to IMS Health

European drug regulator accepts Mylan-Biocon application for biosimilar Pegfilgrastim

The proposed biosimilar Pegfilgrastim, used to treat cancer, is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace

Ajanta Pharma receives US FDA approval for omeprazole capsules

The company has launched omeprazole and sodium bicarbonate capsule, a generic version of Santarus Inc's Zegerid, in two strengths - 20 mg/1100 mg and 40 mg/1100 mg

SPARC licenses epilepsy drug Elepsia XR to Sun Pharma

The company will receive an up-front payment of $10 million from Sun Pharma, which will market the product (levetiracetam extended release tablets) in the US

Biocon introduces insulin glargine in Japan for diabetes patient

The company, through its partner Fujifilm Pharma, aims to capture a significant share of the Japanese glargine market, estimated by IMS Health at $ 144 million

Amgen and Daiichi Sankyo to jointly commercialise biosimilars in Japan

The deal includes several products in late-stage development, including biosimilars of adalimumab, bevacizumab and trastuzumab

Vascon Engineers opens clean room partitioning systems plant in Thane

While clean room partitioning systems are mainly used in pharma and healthcare industry, demand is also expected to come from defence, auto component, semi-conductor and solar sectors

Indian companies gearing up to solve the biosimilars puzzle

US President is pushing for setting the exclusivity period for biologic drugs at 7 years instead of 12. If this happens, Indian companies should be ready for a windfall of opportunities

AMRI completes acquisition of Italian API maker Euticals

The acquisition positions AMRI as one of the largest independent developers and suppliers of active pharmaceutical ingredients (APIs) to the pharmaceutical industry in Europe

Apax Partners acquires subsidiaries of Spanish pharma firm Invent Farma

This follows Apax Partners' recent acquisition of Neuraxpharm Arzneimittel GmbH, a leading German pharmaceutical company